| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2006 | US20060189693 Methods of treatment with lxr agonists |
| 08/24/2006 | US20060189692 Novel anti-proliferative pharmaceutical composition |
| 08/24/2006 | US20060189691 Use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 08/24/2006 | US20060189689 Arginine mimetics as factor Xa inhibitors |
| 08/24/2006 | US20060189688 Use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 08/24/2006 | US20060189687 decreased toxicity; for cytolysis of tumors; gene therapy; immunotherapy |
| 08/24/2006 | US20060189686 Use of a combination of substances to prevent biofouling organisms |
| 08/24/2006 | US20060189685 Formulations of ladostigil tartrate |
| 08/24/2006 | US20060189684 3-Phenylfuran-2-one derivatives as cox-2 inhibitor |
| 08/24/2006 | US20060189683 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof |
| 08/24/2006 | US20060189682 Water soluble prodrugs of COX-2 inhibitors |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189680 Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents |
| 08/24/2006 | US20060189679 C10 cyclopropyl ester substituted taxane compositions |
| 08/24/2006 | US20060189678 4,5-dihydronaphtho[1,2-b]thiophene derivative |
| 08/24/2006 | US20060189677 Treatment of arrhythmia and the production of analgesia and local anesthesia by administering 1-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(3-hydroxy-1-pyrrolidinyl)cyclohexane or a salt |
| 08/24/2006 | US20060189675 Crystalline form of a drug |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | US20060189671 Compounds, compositions, and methods |
| 08/24/2006 | US20060189670 Process for the preparation of anastrozole and intermediates thereof |
| 08/24/2006 | US20060189669 Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy |
| 08/24/2006 | US20060189668 Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK |
| 08/24/2006 | US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 08/24/2006 | US20060189666 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide |
| 08/24/2006 | US20060189665 Oxamide derivatives useful as raf-kinase inhibitors |
| 08/24/2006 | US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 08/24/2006 | US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators |
| 08/24/2006 | US20060189662 Novel liquid preparation |
| 08/24/2006 | US20060189661 3-pyrid-2-yl-5-phenyl-1,2,4-oxadiazoles in which either the pyridine and/or phenyl rings are substituted; useful for treating neurological and psychiatric disorders such as stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, migraines, Parkinson's and Alzheimer's disease |
| 08/24/2006 | US20060189660 5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same |
| 08/24/2006 | US20060189659 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 08/24/2006 | US20060189658 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189655 Methylphenidate derivatives and uses of them |
| 08/24/2006 | US20060189654 Salts of 5-[(R)-2-(2-{4-[4-(2-amino-2-methyl-propoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one |
| 08/24/2006 | US20060189653 Preparing 5-( alpha-haloacetyl)-8-substituted oxy-(1H)-quinolin-2-ones acylating to formthe 5-acetyl, protecting the 8-hydroxy in the presence of a base and solvent, and forming 5-haloacetyl using a halogenating agent; |
| 08/24/2006 | US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization |
| 08/24/2006 | US20060189651 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 08/24/2006 | US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 08/24/2006 | US20060189649 Mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 08/24/2006 | US20060189648 Treating with 5-HT3 agonist selecting from (R) N-1-azabicyclo[2.2.2]oct-3-yl-4,7-dihydro-7-oxothieno[3,2-b]pyridine-6-carboxamide; increasing the pressure of the lower esophageal sphincter, suffering from GERD |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189646 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide |
| 08/24/2006 | US20060189645 Novel 6-phenylphenantridines |
| 08/24/2006 | US20060189644 Lipid-modified immune response modifiers |
| 08/24/2006 | US20060189643 Novel heterocyclic compounds having anti-HBV activity |
| 08/24/2006 | US20060189642 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| 08/24/2006 | US20060189641 Novel 6-phenlyphenanthridines |
| 08/24/2006 | US20060189640 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| 08/24/2006 | US20060189639 Antagonists of the mGlu receptor and uses thereof |
| 08/24/2006 | US20060189638 kinase inhibitor; proliferative diseases such as cancer, cancer metastasis, inflammation, arthritis, and diseases characterized by abnormal or inappropriate angiogenesis |
| 08/24/2006 | US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 08/24/2006 | US20060189636 Inhibitors of E1 activating enzymes |
| 08/24/2006 | US20060189635 Administering oral dosage forms that comprise a dose of a benzisoxazole derivative and dosing structures or sustainable releasing means that provide specified release profiles or, upon dosing, specified pharmacokinetic characteristics; atypical antipsychotics; reduced side effects |
| 08/24/2006 | US20060189633 Preparation of amorphous form of indiplon |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189631 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 08/24/2006 | US20060189630 Mitotic kinesin inhibitors |
| 08/24/2006 | US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent; |
| 08/24/2006 | US20060189628 Compounds useful as chemokine receptor antagonists |
| 08/24/2006 | US20060189627 RAF inhibitor compounds and methods |
| 08/24/2006 | US20060189626 For example, 2-methyl-6'-(4-methyl-piperazin-1-yl)-[3,4']bipyridinyl-3'-carboxylic acid (3,5-bis-trifluoromethyl-benzyl)-methyl-amide; treatment of certain depressive disorders or emesis |
| 08/24/2006 | US20060189625 Cyclic aminophenyl sulfamate derivative |
| 08/24/2006 | US20060189624 Novel combination for treating sexual dysfunction |
| 08/24/2006 | US20060189623 5-Cyano-1H-imidazole-2-carboxylic acid [4-(3,6-dihydro-2H-pyran-4-yl)-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 08/24/2006 | US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189620 Immunosuppressive effects of pteridine derivatives |
| 08/24/2006 | US20060189619 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds |
| 08/24/2006 | US20060189618 6-{4-[2-(4-tert-butyl-phenyl)-1H-imidazo[4,5-c]pyridin-4-yl]-piperazin-1-ylmethyl}quinoxaline; controls biosynthesis and release of sex steroids in the gonads; contraceptive; anticarcinogenic agent; prostate, uterine, breast, ovarian cancer, endometriosis, uterine fibroids, primary hirsutism |
| 08/24/2006 | US20060189617 e.g. 2-(4-tert-butyl-phenyl)-7-[4-(1-ethyl-2-methyl-1H-imidazol-4-ylmethyl)-piperazin-1-yl]-3H-imidazo[4,5-b]pyridine; anticarcinogenic agent; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, or primary hirsutism |
| 08/24/2006 | US20060189616 2-(4-Tert-Butyl-phenyl)-7-[4-(2-ethyl-5-methyl-3H-imidazol-4-ylmethyl)-piperazin-1-yl]-1H-imidazo[4,5-c]pyridine; oral delivery; bioavailability; luteinizing hormone releasing hormone) receptor antagonists; antifertility agents; hormone inhibitors |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189614 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 08/24/2006 | US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) |
| 08/24/2006 | US20060189612 Pharmaceutically active morpholinol |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189610 Peripheral cannabinoid receptor (CB2) selective ligands |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189608 Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
| 08/24/2006 | US20060189607 e.g. 8-(2-{3-[3-(4-fluoro-phenyl)-5-methyl-[1,2,4]triazol-1-yl]-1,1-dimethyl-propylamino}-1-hydroxy-ethyl)-6-hydroxy-4h-benzo[1,4]oxazin-3; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity |
| 08/24/2006 | US20060189606 comprising administering compounds that affect viral internal ribosome entry site (IRES) activity, such as [4-(3-cyano-1-ethyl-6-methoxy-1H-indol-2-yl)-phenyl]-carbamic acid ethyl ester |
| 08/24/2006 | US20060189605 New pharmaceutically-active compounds for the treatment of respiratory diseases |
| 08/24/2006 | US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 08/24/2006 | US20060189603 such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions |
| 08/24/2006 | US20060189602 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction |
| 08/24/2006 | US20060189601 Antibacterial agents |
| 08/24/2006 | US20060189600 Benodiazepine spirohydantoin cgrp receptor antagonists |
| 08/24/2006 | US20060189599 Treating alcohol and or substance abuse by antagonizing alpha 2 adrenergic receptors with weak dopamine blocking |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189596 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists |
| 08/24/2006 | US20060189595 Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
| 08/24/2006 | US20060189594 Procedure for preparing a pharmaceutically active compound |
| 08/24/2006 | US20060189593 Aryl spirohydantoin cgrp receptor antagonists |
| 08/24/2006 | US20060189592 Crystal of 1-methylcarbapenem compound |
| 08/24/2006 | US20060189591 Five-membered heterocyclic derivative |